Katherine E Harrod, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9 Healthcare Drive, Suite 208, Biddeford, ME 04005 Phone: 207-282-7531 Fax: 207-286-3787 |
Katherine K. Yanagisawa, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 9 Healthcare Dr, Biddeford, ME 04005 Phone: 207-282-7531 |
Margaret A Bordeau, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 Fax: 207-286-3787 |
Dr. Cynthia A Patraitis, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 9 Healthcare Dr, Suite 208, Biddeford, ME 04005 Phone: 207-282-7531 Fax: 207-286-3787 |
Christina S Manning, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9 Healthcare Drive, Suite 208, Smmc Primecare Pediatrics, Biddeford, ME 04005 Phone: 207-282-7531 Fax: 207-286-3787 |
Joan D Pelletier, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 9 Healthcare Drive, Suite 208, Biddeford, ME 04005 Phone: 207-282-7531 Fax: 207-286-3787 |
News Archive
Stratasys Ltd. today announced first quarter financial results.
By coupling a kicked-up version of microscopy with gold nanoparticles, investigators at Duke University have been able to peer so deeply into living tissue that they can see molecules interacting.
British pharmaceutical giant GlaxoSmithKline, announced this Thursday that its second-quarter charges related to legal cases involving the two drugs Avandia (diabetes drug) and Paxil (drug for anxiety and depression) would run up to $2.36 billion. Avandia's use and its potential risk of causing heart problems were being debated this week by an advisory panel to the US Food & Drugs Administration (FDA).
Sucampo Pharmaceuticals, Inc. and Abbott today announced the availability of AMITIZA (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases. AMITIZA was approved by the Ministry of Health, Labor and Welfare (MHLW) in Japan in June.
Sanofi Pasteur announced today it has received the first of what is expected to be a series of orders from the U.S. Department of Health and Human Services (HHS) to commence production of a vaccine to help protect against the new influenza A(H1N1) virus.
› Verified 8 days ago